NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP
Smith & Nephew PLC SNN
11 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 6.2B
Revenue, FY2025 · full 11-year series below
Revenue $B
Net income $B
FY2025 · Revenue 6.2 · Net income 0.6
Compound annual growth
+5.7%
+6.2%
+2.9%
+41.0%
+6.9%
+4.3%
+41.1%
+6.9%
+4.6%
+47.3%
+104.6%
+23.5%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at +6.2% a year over five years — but profit grew faster: net income at +6.9%, earnings per share at +6.9%.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
10 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating 12.9% · Net 10.1%
ROE
FY2025 · ROE 11.8%
Each USD of equity produced 12 cents of profit this year.
The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 6.2 | 5.8 | 5.5 | 5.2 | 5.2 | 4.6 | 5.1 | 4.9 | 4.8 | 4.7 | 4.6 |
| Operating income $B | 0.8 | 0.7 | 0.4 | 0.5 | 0.6 | 0.3 | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 |
| EBITDA $B | · | · | 0.6 | 0.7 | 0.8 | 0.5 | 1.0 | 1.0 | 1.4 | 1.2 | 1.1 |
| Income tax $B | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | −0.2 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 |
| Net income $B | 0.6 | 0.4 | 0.3 | 0.2 | 0.5 | 0.4 | 0.6 | 0.7 | 0.8 | 0.8 | 0.4 |
| EPS, diluted $ | 0.72 | 0.47 | 0.30 | 0.26 | 0.60 | 0.51 | 0.60 | 75.70 | 0.88 | 0.88 | 0.46 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | 11.8 | 7.9 | 5.0 | 4.1 | 9.7 | 8.6 | 12.0 | 13.9 | 17.8 | 19.8 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 1 failures in 54 reconciliationsAUDITED
Reconciled in 10 of 19 fiscal years. 41 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente1 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNYSE
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2015